For: | Mizukami K, Murakami K, Abe T, Inoue K, Uchida M, Okimoto T, Kodama M, Fujioka T. Aspirin-induced small bowel injuries and the preventive effect of rebamipide. World J Gastroenterol 2011; 17(46): 5117-5122 [PMID: 22171147 DOI: 10.3748/wjg.v17.i46.5117] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v17/i46/5117.htm |
Number | Citing Articles |
1 |
Ryota Niikura, Atsuo Yamada, Koutarou Maki, Masanao Nakamura, Hirotsugu Watabe, Mitsuhiro Fujishiro, Shiro Oka, Motohiro Esaki, Shunji Fujimori, Atsushi Nakajima, Naoki Ohmiya, Takayuki Matsumoto, Shinji Tanaka, Kazuhiko Koike, Choitsu Sakamoto. Associations between drugs and small‐bowel mucosal bleeding: Multicenter capsule‐endoscopy study. Digestive Endoscopy 2018; 30(1): 79 doi: 10.1111/den.12922
|
2 |
Moe H. Kyaw, Koji Otani, Jessica Y.L. Ching, Akira Higashimori, Ka Man Kee, Toshio Watanabe, Yee Kit Tse, Vivian Lee, Tetsuya Tanigawa, Pui Kuan Cheong, Bing Y. Suen, Yasuhiro Fujiwara, Kelvin Lam, Tetsuo Arakawa, Francis K.L. Chan. Misoprostol Heals Small Bowel Ulcers in Aspirin Users With Small Bowel Bleeding. Gastroenterology 2018; 155(4): 1090 doi: 10.1053/j.gastro.2018.06.056
|
3 |
Xiaoyu Niu, Inge A.M. de Graaf, Hendrik A. van der Bij, Geny M.M. Groothuis. Precision cut intestinal slices are an appropriate ex vivo model to study NSAID-induced intestinal toxicity in rats. Toxicology in Vitro 2014; 28(7): 1296 doi: 10.1016/j.tiv.2014.06.010
|
4 |
E. V. Onuchina. Antiplatelet therapy with acetylsalicylic acid: Approaches to reducing the frequency of gastrointenstinal adverse reactions. Terapevticheskii arkhiv 2014; 86(12): 98 doi: 10.17116/terarkh2014861298-103
|
5 |
Shoko Edogawa, Toshihisa Takeuchi, Yuichi Kojima, Kazuhiro Ota, Satoshi Harada, Takanori Kuramoto, Ken Narabayashi, Takuya Inoue, Kazuhide Higuchi. Current Topics of Strategy of NSAID-Induced Small Intestinal Lesions. Digestion 2015; 92(2): 99 doi: 10.1159/000437395
|
6 |
Yosuke Suyama, Osamu Handa, Yuji Naito, Shun Takayama, Rieko Mukai, Chihiro Ushiroda, Atsushi Majima, Yuriko Yasuda-Onozawa, Yasuki Higashimura, Akifumi Fukui, Osamu Dohi, Tetsuya Okayama, Naohisa Yoshida, Kazuhiro Katada, Kazuhiro Kamada, Kazuhiko Uchiyama, Takeshi Ishikawa, Tomohisa Takagi, Hideyuki Konishi, Yoshito Itoh. Mucus reduction promotes acetyl salicylic acid-induced small intestinal mucosal injury in rats. Biochemical and Biophysical Research Communications 2018; 498(1): 228 doi: 10.1016/j.bbrc.2018.02.202
|
7 |
N. S. Lapina, A. A. Alekseeva, A. D. Vershinina, N. S. Khruleva, D. S. Zlobina, L. Yu. Koroleva. Gastrointestinal Bleeding in Patients with Coronary Heart Disease: Preventive Options. Kardiologiia 2020; 60(7): 125 doi: 10.18087/cardio.2020.7.n942
|
8 |
Dustin L. Cooper, Robert C. Wood, Jarrett E. Wyatt, Sam Harirforoosh. Pharmacokinetic interactions between rebamipide and selected nonsteroidal anti-inflammatory drugs in rats. European Journal of Pharmaceutical Sciences 2014; 53: 28 doi: 10.1016/j.ejps.2013.12.002
|
9 |
Kazuhiro Mizukami, Kazunari Murakami, Yuka Hirashita, Akari Hisamatsu, Ryo Ogawa, Masahiro Uchida, Yoshifumi Nakagawa, Tadayoshi Okimoto, Masaaki Kodama, Toshio Fujioka. Efficacy of rebamipide for low-dose aspirin-related gastrointestinal symptoms. Journal of Clinical Biochemistry and Nutrition 2012; doi: 10.3164/jcbn.12-27
|
10 |
Younghee Choe, Jae Myung Park, Joon Sung Kim, Yu Kyung Cho, Byung-Wook Kim, Myung-Gyu Choi, Na Jin Kim. Drugs Effective for Nonsteroidal Anti-inflammatory Drugs or Aspirin-induced Small Bowel Injuries. Journal of Clinical Gastroenterology 2024; 58(10): 1003 doi: 10.1097/MCG.0000000000001975
|
11 |
Chuan-Guo Guo, Wai K. Leung. Potential Strategies in the Prevention of Nonsteroidal Anti-inflammatory Drugs-Associated Adverse Effects in the Lower Gastrointestinal Tract. Gut and Liver 2020; 14(2): 179 doi: 10.5009/gnl19201
|
12 |
Carmelo Scarpignato, Ingvar Bjarnason. Drug-Induced Small Bowel Injury: a Challenging and Often Forgotten Clinical Condition. Current Gastroenterology Reports 2019; 21(11) doi: 10.1007/s11894-019-0726-1
|
13 |
Toshio Watanabe, Yasuhiro Fujiwara, Francis K. L. Chan. Current knowledge on non-steroidal anti-inflammatory drug-induced small-bowel damage: a comprehensive review. Journal of Gastroenterology 2020; 55(5): 481 doi: 10.1007/s00535-019-01657-8
|
14 |
Jiahui Zhou, Na Li, Xinzhong Li, Jingxue Ye, Min Wang, Guibo Sun. Review on recent advancements in understanding acetylsalicylic acid-induced gastrointestinal injury: mechanisms, medication, and dosage refinement. Naunyn-Schmiedeberg's Archives of Pharmacology 2024; doi: 10.1007/s00210-024-03521-w
|
15 |
Sei Kurokawa, Shinichi Katsuki, Tomoki Fujita, Yusuke Saitoh, Hidetoshi Ohta, Kouji Nishikawa, Yasushi Sato, Yasuhiro Sato, Koji Ohira, Masataka Yamada, Mototsugu Kato. A randomized, double-blinded, placebo-controlled, multicenter trial, healing effect of rebamipide in patients with low-dose aspirin and/or non-steroidal anti-inflammatory drug induced small bowel injury. Journal of Gastroenterology 2014; 49(2): 239 doi: 10.1007/s00535-013-0805-2
|
16 |
Yun Jeong Lim, Hoon Jai Chun. Recent Advances in NSAIDs-Induced Enteropathy Therapeutics: New Options, New Challenges. Gastroenterology Research and Practice 2013; 2013: 1 doi: 10.1155/2013/761060
|
17 |
V. I. Simanenkov, S. V. Tikhonov. Rebamipide: New opportunities of gastroenteroprotection. Terapevticheskii arkhiv 2015; 87(12): 134 doi: 10.17116/terarkh20158712134-137
|
18 |
|
19 |
Toshio Watanabe, Toshihisa Takeuchi, Osamu Handa, Yasuhisa Sakata, Tetsuya Tanigawa, Masatsugu Shiba, Yuji Naito, Kazuhide Higuchi, Kazuma Fujimoto, Toshikazu Yoshikawa, Tetsuo Arakawa, John Green. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of High-Dose Rebamipide Treatment for Low-Dose Aspirin-Induced Moderate-to-Severe Small Intestinal Damage. PLOS ONE 2015; 10(4): e0122330 doi: 10.1371/journal.pone.0122330
|
20 |
Anne Gnauck, Roger G Lentle, Marlena C Kruger. Aspirin-induced increase in intestinal paracellular permeability does not affect the levels of LPS in venous blood of healthy women. Innate Immunity 2015; 21(5): 537 doi: 10.1177/1753425914557101
|
21 |
Hiroki Endo, Eiji Sakai, Takayuki Kato, Shotaro Umezawa, Takuma Higurashi, Hidenori Ohkubo, Atsushi Nakajima. Small bowel injury in low-dose aspirin users. Journal of Gastroenterology 2015; 50(4): 378 doi: 10.1007/s00535-014-1028-x
|
22 |
Takayoshi Suzuki, Aya Masui, Jun Nakamura, Hirokazu Shiozawa, Jun Aoki, Hirohiko Nakae, Shingo Tsuda, Jin Imai, Ozawa Hideki, Masashi Matsushima, Tetsuya Mine, Akira Tamura, Toshihiro Ohtsu, Yukio Asami, Atsushi Takagi. Yogurt Containing <b><i>Lactobacillus gasseri</i></b> Mitigates Aspirin-Induced Small Bowel Injuries: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial. Digestion 2017; 95(1): 49 doi: 10.1159/000452361
|
23 |
Hiroshi Satoh, Kikuko Amagase, Koji Takeuchi. The Role of Food for the Formation and Prevention of Gastrointestinal Lesions Induced by Aspirin in Cats. Digestive Diseases and Sciences 2013; 58(10): 2840 doi: 10.1007/s10620-013-2725-7
|
24 |
Foong Way David Tai, Mark E. McAlindon. NSAIDs and the small bowel. Current Opinion in Gastroenterology 2018; 34(3): 175 doi: 10.1097/MOG.0000000000000427
|
25 |
Dong Han Yeom, Han Seung Ryu. Effects of Misoprostol for Aspirin-induced Small Bowel Enteropathy. The Korean Journal of Gastroenterology 2019; 73(1): 60 doi: 10.4166/kjg.2019.73.1.60
|
26 |
A. E. Karateev, E. V. Moroz, E. V. Kryukov. Small intestinal damage associated with the use of nonsteroidal anti-inflammatory drugs. Almanac of Clinical Medicine 2019; 47(6): 559 doi: 10.18786/2072-0505-2019-47-048
|
27 |
I. A. Viktorova, D. I. Trukhan, D. S. Ivanova. Modern opportunities for treatment and prevention of NSAID-induced enteropathies. Meditsinskiy sovet = Medical Council 2020; (5): 30 doi: 10.21518/2079-701X-2020-5-30-40
|
28 |
E. N. Kareva. NSAID enteropathy. Terapevticheskii arkhiv 2020; 92(2): 85 doi: 10.26442/00403660.2020.02.000453
|
29 |
Tetsuya Tanigawa, Toshio Watanabe, Akira Higashimori, Sunao Shimada, Hiroyuki Kitamura, Takuya Kuzumoto, Yuji Nadatani, Koji Otani, Shusei Fukunaga, Shuhei Hosomi, Fumio Tanaka, Noriko Kamata, Yasuaki Nagami, Koichi Taira, Masatsugu Shiba, Wataru Suda, Masahira Hattori, Yasuhiro Fujiwara, Jan S Suchodolski. Rebamipide ameliorates indomethacin-induced small intestinal damage and proton pump inhibitor-induced exacerbation of this damage by modulation of small intestinal microbiota. PLOS ONE 2021; 16(1): e0245995 doi: 10.1371/journal.pone.0245995
|
30 |
Eun Young Kim, Ji Hyun Kim, Saet Byul Woo, Jeong Won Lee, Kon Hee Lee, Su Rin Shin, Jee Hyun Lee. A Case of Small Bowel Ulcer Associated withHelicobacter pylori. Pediatric Gastroenterology, Hepatology & Nutrition 2012; 15(4): 266 doi: 10.5223/pghn.2012.15.4.266
|
31 |
Yu Lai, Wa Zhong, Tao Yu, Zhong-Sheng Xia, Jie-Yao Li, Hui Ouyang, Ti-Dong Shan, Hong-Sheng Yang, Qi-Kui Chen, Kjetil Tasken. Rebamipide Promotes the Regeneration of Aspirin-Induced Small-Intestine Mucosal Injury through Accumulation of β-Catenin. PLOS ONE 2015; 10(7): e0132031 doi: 10.1371/journal.pone.0132031
|
32 |
Massimo Montalto, Antonella Gallo, Antonio Gasbarrini, Raffaele Landolfi. NSAID enteropathy: could probiotics prevent it?. Journal of Gastroenterology 2013; 48(6): 689 doi: 10.1007/s00535-012-0648-2
|
33 |
Yuichi Kojima, Toshihisa Takeuchi, Kazuhiro Ota, Satoshi Harada, Shoko Edogawa, Ken Narabayashi, Sadaharu Nouda, Toshihiko Okada, Kazuki Kakimoto, Takanori Kuramoto, Takuya Inoue, Kazuhide Higuchi. Effect of long-term proton pump inhibitor therapy and healing effect of irsogladine on nonsteroidal anti-inflammatory drug-induced small-intestinal lesions in healthy volunteers. Journal of Clinical Biochemistry and Nutrition 2015; 57(1): 60 doi: 10.3164/jcbn.15-32
|
34 |
Junseok Park, Seong Ran Jeon, Jin‐Oh Kim, Hyun Gun Kim, Tae Hee Lee, Jun‐Hyung Cho, Bong Min Ko, Joon Seong Lee, Moon Sung Lee. Rebleeding rate and risk factors in nonsteroidal anti‐inflammatory drug‐induced enteropathy. Journal of Digestive Diseases 2018; 19(5): 279 doi: 10.1111/1751-2980.12600
|
35 |
Wan-tong Zhang, Miao-ran Wang, Guo-dong Hua, Qiu-yan Li, Xu-jie Wang, Rui Lang, Wei-liang Weng, Chun-miao Xue, Bao-chen Zhu. Inhibition of Aspirin-Induced Gastrointestinal Injury: Systematic Review and Network Meta-Analysis. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.730681
|
36 |
Kazuhiro Ota, Toshihisa Takeuchi, Yuichi Kojima, Satoshi Harada, Yuki Hirata, Noriaki Sugawara, Sadaharu Nouda, Kazuki Kakimoto, Takanori Kuramoto, Kazuhide Higuchi. Preventive effect of ecabet sodium on low-dose aspirin-induced small intestinal mucosal injury: a randomized, double-blind, pilot study. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-018-0923-7
|
37 |
Takahiro Beppu, Masashi Yamaguchi, Shotaro Nakamura, Kozue Tsurumi, Yoichiro Ono, Mitsue Sogawa, Kenji Watanabe, Takashi Watanabe, Motohiro Esaki, Naoya Kubokura, Fumihito Hirai, Hideki Ishibashi, Satoshi Ishikawa, Tomoko Nawata, Yoshitaka Tomioka. Endoscopy in the Diagnosis of Small Intestine Diseases. 2014; : 135 doi: 10.1007/978-4-431-54352-7_19
|
38 |
Kazuhiro Ota, Toshihisa Takeuchi, Sadaharu Nouda, Haruhiko Ozaki, Shinpei Kawaguchi, Yoshiaki Takahashi, Satoshi Harada, Shoko Edogawa, Yuichi Kojima, Takanori Kuramoto, Kazuhide Higuchi. Determination of the adequate dosage of rebamipide, a gastric mucoprotective drug, to prevent low-dose aspirin-induced gastrointestinal mucosal injury. Journal of Clinical Biochemistry and Nutrition 2016; 59(3): 231 doi: 10.3164/jcbn.16-49
|
39 |
A I Parfenov, O V Akhmadullina, E A Sabelnikova, N I Belostotsky, M V Kirova, S G Khomeriki, S V Bykova. Disaccharidase deficiency and functional bowel diseases. Terapevticheskii arkhiv 2017; 89(4): 45 doi: 10.17116/terarkh201789445-52
|
40 |
Katsuyuki Tozawa, Tadayuki Oshima, Takuya Okugawa, Tomohiro Ogawa, Yoshio Ohda, Toshihiko Tomita, Nobuyuki Hida, Hirokazu Fukui, Kazutoshi Hori, Jiro Watari, Shiro Nakamura, Hiroto Miwa. A Randomized, Double-Blind, Placebo-Controlled Study of Rebamipide for Gastric Mucosal Injury Taking Aspirin With or Without Clopidogrel. Digestive Diseases and Sciences 2014; 59(8): 1885 doi: 10.1007/s10620-014-3108-4
|
41 |
Krums LM, Ahmadullin OV, Bykova SV, Babanova AV, Parfenov AI. The use of rebampid in celiac therapy as a possible reason for rapid complete remission. Clinicalfollow-up. Gastroenterology & Hepatology: Open Access 2021; 12(6): 162 doi: 10.15406/ghoa.2021.12.00479
|
42 |
Osamu Handa, Shun Takayama, Rieko Mukai, Yosuke Suyama, Atsushi Majima, Akifumi Fukui, Tatsushi Omatsu, Yuji Naito. A review of the mechanism and prophylaxis of acetyl salicylic acid-induced injury of the small intestine. Free Radical Research 2018; 52(11-12): 1266 doi: 10.1080/10715762.2018.1455003
|
43 |
M.V. Bielsa-Fernández, J.L. Tamayo-de la Cuesta, J. Lizárraga-López, J.M. Remes-Troche, R. Carmona-Sánchez, J.M. Aldana-Ledesma, J.M. Avendaño-Reyes, M.A. Ballesteros-Amozorrutia, M. De Ariño, L. de Giau-Triulzi, R. Flores-Rendón, H. Huerta-Guerrero, J.A. González-González, A. Hernández-Guerrero, E. Murcio-Pérez, J.O. Jáquez-Quintana, A. Meixueiro-Daza, J.R. Nogueira-de Rojas, H. Rodríguez-Hernández, R. Santoyo-Valenzuela, S.C. Solorzano-Olmos, L.F. Uscanga-Domínguez, F. Zamarripa-Dorsey. Consenso mexicano sobre diagnóstico, prevención y tratamiento de la gastropatía y enteropatía por antiinflamatorios no esteroideos. Revista de Gastroenterología de México 2020; 85(2): 190 doi: 10.1016/j.rgmx.2019.11.003
|
44 |
Mohamed Hasif Jaafar, Sher Zaman Safi, Maw-Pin Tan, Sanjay Rampal, Sanjiv Mahadeva. Efficacy of Rebamipide in Organic and Functional Dyspepsia: A Systematic Review and Meta-Analysis. Digestive Diseases and Sciences 2018; 63(5): 1250 doi: 10.1007/s10620-017-4871-9
|
45 |
Damian Maseda, Emanuela Ricciotti. NSAID–Gut Microbiota Interactions. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.01153
|
46 |
M.V. Bielsa-Fernández, J.L. Tamayo-de la Cuesta, J. Lizárraga-López, J.M. Remes-Troche, R. Carmona-Sánchez, J.M. Aldana-Ledesma, J.M. Avendaño-Reyes, M.A. Ballesteros-Amozorrutia, M. De Ariño, L. de Giau-Triulzi, R. Flores-Rendón, H. Huerta-Guerrero, J.A. González-González, A. Hernández-Guerrero, E. Murcio-Pérez, J. Jáquez-Quintana, A. Meixueiro-Daza, J.R. Nogueira-de Rojas, H. Rodríguez-Hernández, R. Santoyo-Valenzuela, S.C. Solorzano-Olmos, L.F. Uscanga-Domínguez, F. Zamarripa-Dorsey. The Mexican consensus on the diagnosis, treatment, and prevention of NSAID-induced gastropathy and enteropathy. Revista de Gastroenterología de México (English Edition) 2020; 85(2): 190 doi: 10.1016/j.rgmxen.2019.11.001
|
47 |
Dong Jun Oh, Hyuk Yoon, Hyun Soo Kim, Yoon Jin Choi, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee, You-Jung Ha, Eun Ha Kang, Yun Jong Lee, Nayoung Kim, Ki-Jeoung Kim, Fei Liu. The effect of rebamipide on non-steroidal anti-inflammatory drug-induced gastro-enteropathy: a multi-center, randomized pilot study. The Korean Journal of Internal Medicine 2022; 37(6): 1153 doi: 10.3904/kjim.2021.216
|
48 |
Azusa Hara, Kazuhiro Ota, Toshihisa Takeuchi, Yuichi Kojima, Yuki Hirata, Haruhiko Ozaki, Shinpei Kawaguchi, Yoshiaki Takahashi, Satoshi Harada, Taisuke Sakanaka, Takeshi Ogura, Sadaharu Nouda, Kazuki Kakimoto, Ken Kawakami, Akira Asai, Shinya Fukunishi, Makoto Sanomura, Kazunari Tominaga, Kazuhide Higuchi. Dual antiplatelet therapy does not affect the incidence of low-dose aspirin-induced small intestinal mucosal injury in patients after percutaneous coronary intervention for coronary stenosis: a multicenter cross-sectional study. Journal of Clinical Biochemistry and Nutrition 2018; 63(3): 224 doi: 10.3164/jcbn.18-16
|
49 |
Shaoheng Zhang, Qing Qing, Yang Bai, Hua Mao, Wei Zhu, Qikui Chen, Yali Zhang, Ye Chen. Rebamipide Helps Defend Against Nonsteroidal Anti-Inflammatory Drugs Induced Gastroenteropathy: A Systematic Review and Meta-Analysis. Digestive Diseases and Sciences 2013; 58(7): 1991 doi: 10.1007/s10620-013-2606-0
|
50 |
Hiroyuki Tsujimoto, Yuki Hirata, Yasuhiro Ueda, Naohiko Kinoshita, Hideki Tawa, Yasuyoshi Tanaka, Ryoji Koshiba, Kazuhiro Ota, Yuichi Kojima, Kazuki Kakimoto, Toshihisa Takeuchi, Takako Miyazaki, Shiro Nakamura, Kazuhide Higuchi. Effect of a proton-pump inhibitor on intestinal microbiota in patients taking low-dose aspirin. European Journal of Clinical Pharmacology 2021; 77(11): 1639 doi: 10.1007/s00228-021-03167-0
|
51 |
Yuriko Yasuda-Onozawa, Osamu Handa, Yuji Naito, Chihiro Ushiroda, Yosuke Suyama, Yuki Toyokawa, Takaaki Murakami, Tomoyo Yasuda, Tomohiro Ueda, Atsushi Majima, Yuma Hotta, Toshifumi Doi, Makoto Tanaka, Yusuke Horii, Yasuki Higashimura, Katsura Mizushima, Mayuko Morita, Yukiko Uehara, Hideki Horie, Akifumi Fukui, Osamu Dohi, Tetsuya Okayama, Naohisa Yoshida, Kazuhiro Kamada, Kazuhiro Katada, Kazuhiko Uchiyama, Takeshi Ishikawa, Tomohisa Takagi, Hideyuki Konishi, Yoshito Itoh. Rebamipide upregulates mucin secretion of intestinal goblet cells via Akt phosphorylation. Molecular Medicine Reports 2017; 16(6): 8216 doi: 10.3892/mmr.2017.7647
|